Ajanta Pharma Ltd (BOM:532331)
₹ 2840.05 -15.35 (-0.54%) Market Cap: 354.76 Bil Enterprise Value: 347.51 Bil PE Ratio: 40.83 PB Ratio: 9.65 GF Score: 99/100

Q1 2022 Ajanta Pharma Ltd Earnings Call Transcript

Jul 29, 2021 / 12:00PM GMT
Release Date Price: ₹1596.1 (+2.85%)
Operator

Ladies and gentlemen, good day, and welcome to Ajanta Pharma Limited Q1 FY22 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Yogesh Agarwal, Managing Director of Ajanta Pharma Limited. Thank you, and over to you sir.

Yogesh Agarwal
Ajanta Pharma Limited - MD

Thank you. Good evening, and welcome, everyone. With me, I have Mr. Rajesh Agarwal, our Joint Managing Director, and Mr. Arvind Agrawal, our CFO. So before we move on to the business our thoughts and prayers are with everyone who suffered the effects of the second wave of COVID and especially to those who have lost their loved ones.

Recognizing that vaccination was our best back to an early return to the normalcy. We started the vaccination drive across all our locations starting in March. This covered not only Ajantaites but also their family members and I'm happy to say that over 88% of our Ajantaites have been vaccinated with at least one shot. As we speak national vaccination program is also progressing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot